Android app Apple app link

Revance Therapeutics, Inc. (RVNC) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$3.65

south_east
-$0 (0%)
Day's range
$3.65
Day's range
$3.65

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/17/2024 Mizuho Securities Vamil Divan $6.66 $5.96   11.84%
05/10/2024 Piper Sandler David Amsellem $11.00 $3.74   194.51%
05/10/2024 H.C. Wainwright Douglas Tsao $11.00 $4.29   156.41%
05/10/2024 Mizuho Securities Vamil Divan $8.00 $3.73   114.47%
09/20/2023 Needham Serge Belanger $35.00 $13.48   159.64%
08/25/2022 Wells Fargo Jacob Hughes $24.00 $21.26   12.89%

Revance Therapeutics, Inc. FAQ's

Revance Therapeutics, Inc. has been rated by research analysts at Mizuho Securities, Piper Sandler, H.C. Wainwright, Needham, Barclays, Wells Fargo in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.